In animal studies, AOD-9604 treatment reduced body weight gain by over 50% compared to controls over a 19-day period, with increased lipolytic activity in adipose tissue
Hence they look and feel a whole lot better
Moreover, it lacks the broad metabolic effects that weight loss drugs often exhibit, such as appetite suppression or changes in basal metabolic rate
Semaglutide, on the other hand, is a GLP-1 receptor agonist originally designed to manage type 2 diabetes
Dissecting B12 Shots & Injections: Investigating the Definite Benefits and Risks of B12 Inkections, Alongside Alternative Options
Unlike traditional growth hormones, AOD9604 does not seem to have effects on blood sugar regulation or insulin levels, making it a focal point in therapies designed for weight reduction and body composition improvement